CY1110229T1 - TRIAZOLOPYRAZINE COMPOUNDS USEFUL FOR TREATMENT OF DEFENSE & INFLAMMATORY DISEASES - Google Patents

TRIAZOLOPYRAZINE COMPOUNDS USEFUL FOR TREATMENT OF DEFENSE & INFLAMMATORY DISEASES

Info

Publication number
CY1110229T1
CY1110229T1 CY20101100682T CY101100682T CY1110229T1 CY 1110229 T1 CY1110229 T1 CY 1110229T1 CY 20101100682 T CY20101100682 T CY 20101100682T CY 101100682 T CY101100682 T CY 101100682T CY 1110229 T1 CY1110229 T1 CY 1110229T1
Authority
CY
Cyprus
Prior art keywords
defense
treatment
inflammatory diseases
compounds useful
triazolopyrazine
Prior art date
Application number
CY20101100682T
Other languages
Greek (el)
Inventor
Martin James Inglis Andrews
Paul Edwards
Mark Stuart Chambers
Wolfgang Schmidt
Juha Andrew Clase
Gregory Bar
Kim Louise Hirst
Angus Macleod
Original Assignee
Galapagos N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07729660A external-priority patent/EP2029602B1/en
Application filed by Galapagos N.V. filed Critical Galapagos N.V.
Publication of CY1110229T1 publication Critical patent/CY1110229T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Αποκαλύπτοντα νέες ενώσεις [1.2.4] τριαζολο [1,5-a] πυραζίνης οι οποίες έχουν έναν τύπο που αντιπροσωπεύεται από τον ακόλουθο (τύπο Ι). Οι ενώσεις μπορεί να παρασκευάζονται ως φαρμακευτικές συνθέσεις, και μπορεί να χρησιμοποιηθούν για την πρόληψη μιας ποικιλίας καταστάσεων σε θηλαστικά που περιλαμβάνουν ανθρώπους, συμπεριλαμβάνοντας ως μη περιοριστικό παράδειγμα, αρθρίτιδα, φλεγμονή, και άλλα.Revealing new compounds [1.2.4] triazolo [1,5-a] pyrazine having a formula represented by the following (formula I). The compounds may be prepared as pharmaceutical compositions, and may be used to prevent a variety of conditions in mammals involving humans, including as a non-limiting example, arthritis, inflammation, and more.

CY20101100682T 2006-05-31 2010-07-21 TRIAZOLOPYRAZINE COMPOUNDS USEFUL FOR TREATMENT OF DEFENSE & INFLAMMATORY DISEASES CY1110229T1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US80355206P 2006-05-31 2006-05-31
US93184407P 2007-05-25 2007-05-25
US93176407P 2007-05-25 2007-05-25
US93176307P 2007-05-25 2007-05-25
US93210007P 2007-05-29 2007-05-29
EP07729660A EP2029602B1 (en) 2006-05-31 2007-05-30 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases

Publications (1)

Publication Number Publication Date
CY1110229T1 true CY1110229T1 (en) 2015-01-14

Family

ID=42664733

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100682T CY1110229T1 (en) 2006-05-31 2010-07-21 TRIAZOLOPYRAZINE COMPOUNDS USEFUL FOR TREATMENT OF DEFENSE & INFLAMMATORY DISEASES

Country Status (1)

Country Link
CY (1) CY1110229T1 (en)

Similar Documents

Publication Publication Date Title
NO20084703L (en) Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
UA100007C2 (en) Heterocyclic inhibitors of mek, use thereof and pharmaceutical composition containing thereof
EA200700902A1 (en) 3-ARYLAMINOPYRIDINE DERIVATIVES
ATE369370T1 (en) SUBSTITUTED 2H-(1,2,4)TRIAZOLO(4,3-A)PYRAZINE AS GSK-3 INHIBITORS
EP2086540B8 (en) Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases
ECSP055844A (en) NEW TRICYCLE COMPOUNDS
CR20110092A (en) NEW USEFUL COMPOUNDS FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
BRPI0416692A (en) heterocyclic mek inhibitors and methods of using these
EA200900613A1 (en) SPIROKETONE ACETYL-COA-CARBOXYLAS INHIBITORS
CR8559A (en) PIRAZOLOPIRIMIDINAS
GEP20094720B (en) Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors
CY1113651T1 (en) ANTI-INFLAMMATORY PREPARATIONS
ECSP056006A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVE AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNOLOGICALLY MEDIATED DISEASES
WO2005105770A3 (en) Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
CR11823A (en) USEFUL FUSIONED PIRAZINE COMPOUNDS FOR THE TREATMENT OF DEGENARATIVE AND INFLAMMATORY DISEASES
EA201000432A1 (en) FUNGICIDAL MIXTURES OF TRITICONAZOL AND DIPHENOCONAZOLE
CY1110229T1 (en) TRIAZOLOPYRAZINE COMPOUNDS USEFUL FOR TREATMENT OF DEFENSE & INFLAMMATORY DISEASES
EA200701835A1 (en) AMIDIC DERIVATIVES AS THE LIGANDS OF IONIC CHANNELS, THEIR PHARMACEUTICAL COMPOSITIONS AND METHODS OF THEIR APPLICATION
UY33010A (en) FUSIONATED PIRAZINE COMPOUNDS AS THEIR SALTS, USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
EA200870287A1 (en) AMIDIC DERIVATIVES AS THE LIGANDS OF IONAL CHANNELS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF THEIR APPLICATION
BRPI0506996A (en) organic compounds
ECSP10010663A (en) USEFUL FUSIONED PIRAZINE COMPOUNDS FOR THE TREATMENT OF DEGENARATIVE AND INFLAMMATORY DISEASES
EA200600831A1 (en) FUNGICIDAL MIXTURES, IN PARTICULAR, TO FIGHT ROSE PATHOGENS
TH112056B (en) Biccloheteroaryyl compounds as a P2x7 regulator and their use